PromarkerD
Business Services · Italy · 11-50 Employees
View Company Info for Free
Overview
Headquarters
ItalyPhone Number
+61 893891992Website
www.promarkerd.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About PromarkerD
PromarkerD-Home offers a blood test designed to predict the onset of chronic kidney disease (CKD) up to four years before symptoms appear, specifically targeting individuals with type 2 diabetes and healthcare providers. The test analyzes plasma protein biomarkers to assess kidney disease risk, categorizing patients into low, moderate, or high-risk groups. This enables clinicians to create personalized management plans that can slow or stop the progression of CKD, ultimately improving patient quality of life and reducing healthcare costs. PromarkerD-Home aims to enhance early detection and intervention strategies for chronic kidney disease.Explore more
Popular SearchesPromarkerDPromarker LLCSIC Code 87,873NAICS Code 54,541Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PromarkerD your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
PromarkerD, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on PromarkerD recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if PromarkerD is spiking on competitors!
Check if PromarkerD has recently received funding, and reach out quickly before it becomes old news!
Click to see if PromarkerD had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at PromarkerD
Funding: Get notified immidiatlly once PromarkerD has new funding data
Product Launch: Get notified when PromarkerD launches new products
Recommended Actions
Reach out to Masked Content who joined PromarkerD as Masked Content
Find more new buyers
PromarkerD Tech Stack
A closer look at the technologies used by PromarkerD
See more technologies
PromarkerD News & Media
PromarkerD distribution network expands to Britain
World's first predictive diagnostic test for diabetic kidney disease to be sold in Great Britain under distribution deal with global diagnostic distributor, Apacor Limited Apacor will become the exclusive distributor for PromarkerD in Great Britain (England, Scotland and Wales) Estimated 4.8 million people or seven per cent of the British population live with diabetes, according to Diabetes UK - these patients could benefit from regular PromarkerD testing The UK's National Health Service (NHS) sPromarkerD significantly outperforms current standard of care tests in predicting future kidney function decline
Study shows PromarkerD is significantly better than current standard of care tests eGFR and ACR for predicting future decline in kidney function in patients with type 2 diabetes PromarkerD correctly identified 84% of patients with normal kidney function that went on to experience kidney...Diabetes treatment lowers PromarkerD risk score for diabetic kidney disease
BRISBANE, Australia, Aug. 12, 2021 /PRNewswire/ -- Treatment with diabetes drug canagliflozin lowers the PromarkerD risk score for developing diabetic kidney disease in patients with type 2 diabetes, latest research suggests. In a study presented at the Australasian Diabetes Congress...
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding PromarkerD
Sign Up For FreeTo access detailed company insights
PromarkerD-Home offers a blood test designed to predict the onset of chronic kidney disease (CKD) up to four years before symptoms appear, specifically targeting individuals with type 2 diabetes and healthcare providers. The test analyzes plasma protein biomarkers to assess kidney disease risk, categorizing patients into low, moderate, or high-risk... Read More
